Cardiovascular disease (CVD) represents the leading cause of morbidity and mortality worldwide resulting in approximately one third of all deaths globally [1,2]. Despite significant advances in health care over the last 60 years, the global CVD burden continues to increase due to higher prevalence of CVD risk factors. In the US diabetes and obesity increased among young adults from 2009 to March 2020, while hypertension did not change and hyperlipidaemia declined [3,4]. However, in medium and low-income countries all CV risk factors tend to increase [5–7].
